![Third Rock Ventures Launches Casma Therapeutics with $58.5 Million Investment to Harness the Cellular Process of Autophagy to Develop Breakthrough Therapies - Casma Therapeutics Third Rock Ventures Launches Casma Therapeutics with $58.5 Million Investment to Harness the Cellular Process of Autophagy to Develop Breakthrough Therapies - Casma Therapeutics](https://www.casmatx.com/wp-content/uploads/2022/07/banner-image.jpg)
Third Rock Ventures Launches Casma Therapeutics with $58.5 Million Investment to Harness the Cellular Process of Autophagy to Develop Breakthrough Therapies - Casma Therapeutics
![Alexis Borisy, Partner of Third Rock Ventures LLC., attends the EmTech China at the China World Hotel in Beijing, China, 29 January 2018. The EmTech Stock Photo - Alamy Alexis Borisy, Partner of Third Rock Ventures LLC., attends the EmTech China at the China World Hotel in Beijing, China, 29 January 2018. The EmTech Stock Photo - Alamy](https://c8.alamy.com/comp/W6KNKF/alexis-borisy-partner-of-third-rock-ventures-llc-attends-the-emtech-china-at-the-china-world-hotel-in-beijing-china-29-january-2018-the-emtech-W6KNKF.jpg)
Alexis Borisy, Partner of Third Rock Ventures LLC., attends the EmTech China at the China World Hotel in Beijing, China, 29 January 2018. The EmTech Stock Photo - Alamy
![Confidential | © 2013 Third Rock Ventures Building Biotechnology Companies from Scratch: Strategy and Approaches Robert I. Tepper, MD PAGE1. - ppt download Confidential | © 2013 Third Rock Ventures Building Biotechnology Companies from Scratch: Strategy and Approaches Robert I. Tepper, MD PAGE1. - ppt download](https://slideplayer.com/5681551/18/images/slide_1.jpg)